Cigna

Equities

CI

US1255231003

Managed Healthcare

Real-time Estimate Cboe BZX Other stock markets 11:01:40 2024-09-09 am EDT			5-day change	1st Jan Change
358.68 ^USD	+1.47%		-1.98%	+19.64%

Sep. 05	Transcript : The Cigna Group Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM
Sep. 05	Cigna's Evernorth to Make Stelara Biosimilar Available to Patients From Early 2025	MT

This article is reserved for members

To unlock the article, REGISTER!

100% Free Registration

Already a customer? Log In

Latest news about Cigna

Transcript : The Cigna Group Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-05-2024 10:45 AM	Sep. 05
Cigna's Evernorth to Make Stelara Biosimilar Available to Patients From Early 2025	Sep. 05	MT
Raymond James Adjusts Price Target on Cigna Group to $415 From $400, Maintains Strong Buy Rating	Sep. 03	MT
Celltrion Usa Partners with Express Scripts and Cigna Healthcare to Expand Access to Zymfentra® (Infliximab-Dyyb), the First and Only Fda-Approved Subcutaneous Infliximab on Their Medical Benefit Formulary	Aug. 28	CI
Dave Guilmette Steps Down from Alight, Inc. Board's Audit Committee	Aug. 26	CI
JPMorgan Adjusts Price Target on Cigna Group to $438 From $435, Maintains Overweight Rating	Aug. 21	MT
Venture capital firms making bets on maternal health	Aug. 19	RE
Deutsche Bank Raises Cigna Group's Price Target to $398 From $370	Aug. 02	MT
Wells Fargo Adjusts Price Target on Cigna Group to $355 From $349	Aug. 02	MT
Barclays Adjusts Price Target on Cigna to $405 From $393	Aug. 02	MT
Global markets live: Shell, Chevron, Boeing, Walt Disney, Qualcomm...	Aug. 01
Tranche Update on The Cigna Group (NYSE:CI)'s Equity Buyback Plan announced on December 20, 2018.	Aug. 01	CI
The Cigna Group Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	Aug. 01	CI
Transcript : The Cigna Group, Q2 2024 Earnings Call, Aug 01, 2024	Aug. 01
Stock Futures Rise Ahead of Apple, Amazon Earnings; Asia Churns, Europe Down	Aug. 01	MT
Cigna Group's Q2 Adjusted Earnings, Revenue Increase; Reaffirms 2024 Guidance	Aug. 01	MT
Earnings Flash (CI) THE CIGNA GROUP Reports Q2 EPS $6.72, vs. Street Est of $6.42	Aug. 01	MT
Earnings Flash (CI) THE CIGNA GROUP Posts Q2 Revenue $60.52B, vs. Street Est of $58.35B	Aug. 01	MT
Earnings Flash (CI) THE CIGNA GROUP Reports Q2 EPS $6.72, vs. Street Est of $6.42	Aug. 01	MT
Cigna beats profit estimates on lower-than-expected costs, pharmacy benefit boost	Aug. 01	RE
AbbVie lifts annual profit forecast on strong immunology drug sales	Jul. 25	RE
Cigna Group Keeps Quarterly Dividend at $1.40 per Share, Payable Sept. 19 to Shareholders of Record Sept. 4	Jul. 24	MT
The Cigna Group Declares Quarterly Dividend, Payable on September 19, 2024	Jul. 24	CI
US drug industry middlemen defend business model amid accusations of raising patient costs	Jul. 23	RE
Drug middlemen push for pricier medicines, US House committee report finds	Jul. 23	RE

Chart Cigna

Duration

Period

More charts

Company Profile

The Cigna Group specializes in health services. The activity is organized mainly around 2 sectors: - development of health insurance programs; - development of healthcare management solutions.

Employees

71,413

Sector

Managed Healthcare

Calendar

2024-10-31 - Q3 2024 Earnings Release

Related indices

S&P 500

More about the company